Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

20.40
Delayed Data
As of Apr 20
 -0.05 / -0.24%
Today’s Change
11.85
Today|||52-Week Range
21.01
+46.24%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a -21.57% decrease from the last price of 20.40.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$16.1M
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -347.22%
 
 
 
 
 
 
Growthannually -1.42%
 
 
 
 
 
 

Sales

Growthquarterly -75.09%
 
 
 
 
 
 
Growthannually -15.58%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.